List of the 700 largest Biotech Venture Capital Investors [2022]

249,99 

 

Icons Thousandinvestors

This list includes 700 venture capital investors from our global venture capital investor list that mention biotech and life sciences related keywords on their website. Many of the included venture capital funds are focused on investments in oncology, immunology, mRNA and other drug discovery areas.

The list includes email addresses, investment focus, country information and keyword-related metrics. The list was created on November 2nd, 2022. 

You can get a free preview file upon request via contact [at] thousandinvestors.com.

The list is based on our list of the world’s 2,500 largest venture capital investors.

___

You might also like the list of biotech investor single family offices curated by our partner portal familyofficehub.io.

Description

biotech venture capital investor list

List of 3 biotech venture capital investors

In the following, we are highlighting three different interesting venture capital investors from our keyword crawler-based list.

1. MPM Capital (United States)

With an average keyword rate of 6% per page, MPM Capital is leading our biotech-focused investor lists. The US-based venture capital investor is focused on early-stage funds. Its affiliate company BioImpact capital follows with public equities and private/public funds. The US-based biotech investor has dozens of successful exits. For instance, Cellerant Therapeutics, which was focused on immunotherapy and blood-related illnesses; Dragonfly Sciences, which was focused on novel biosimilars, or Elixir Pharmaceuticals, which works on pharmaceuticals for metabolic illnesses. Current investments include Atkis Oncology (radiopharmaceuticals), Dyne Therapeutics (RNA-based therapies) or Harpoon Therapeutics (T-cell redirecting antibodies).

2. Sofinnova Partners (France)

Sofinnova partners is a leading investor in healthcare startups. The French venture capital investor runs different strategies. Its “Capital Strategy” focuses on groundbreaking therapeutics in early-stage biotech companies. The fund also runs its own medtech accelerator and crossover investment strategies as well as “industrial biotech”. Portfolio companies include AAvantgarde Bio, which is working on adeno-based virus platforms for gene therapy applications. Portfolio company Delinia is a biotech firm working on T Cell-based therapries to cure autoimmune diseases and cancer. Their firm was acquired by Celgene. Inventiva, another portfolio company, is a clinical-stage firm based on small molecule approaches against fibrosis, cancer and lysosomal disorders.

3. Seroba Life Sciences (Ireland)

Also Seroba Life Sciences is one of the top investors in our biotech list. The firm has dozens of successful exits and portfolio companies. For instance, Shorla Oncology is an Irish oncology pharma firm. Or, Coave Therapeutics is focusing on gene therapies. Whereas Atlantic Therapeutics works on neuromuscular stimulation devices.

Picture Source: Pawel Czwerinski

immunology mrna oncology startup investor database

Included information in our biotech investor list

Our keyword analysis-based list include the following general columns:

  • Name of the VC fund
  • Country of origin
  • URL
  • E-mail (general)
  • Investment focus (if data available)
  • Corporate VC (yes/no)

The following columns are based on the keyword crawler, which is a Python-based, in-house developed tool that crawls every page for at least 45 seconds to find the respective keywords.

  • total_frequency (e.g.: 16) – total counted occurrences of keywords on the VC website
  • average_keyword_rate (e.g. 0.1) – average rate of keyword occurrences per subpage in relation with total number of words
  • most_common_keyword (e.g. „biotech“) – keyword that was counted the most often on respective VC website
  • most_common_keyword_frequency (e.g. 10) – number of times the most common keyword was counted
  • sub_url_highest_rate (e.g. https://venturecapitalinvestors.de/biotech) – sub url with the highest number of found keywords
  • highest_rate (e.g. 0.1) – highest keyword rate per subpage
  • frequency_per_keyword:{‘life sciences’: 0, ‘life science’: 0, ‘pharma’: 10, ‘pharmaceutical’: 7, ‘biotech’: 16, ‘clinical development’: 0, ‘drug development’: 0, ‘drug discovery’: 0, ‘oncology’: 73, ‘immunology’: 0, ‘mrna’: 1, ‘virology’: 0} – dictionary of number of keyword occurrences per keyword

Picture Source: Hal Gatewood

Results of our keyword analysis

In the next paragraph, we are focusing on insights derived from our keyword research, which was based on our list of the 2,500 largest VC investors worldwide.

biotech venture capital investor coverage rate

Percentage of VC funds that invest in biotech and life sciences

Our keyword crawler analyzed more than 2,500 venture capital funds regarding biotech and life science investment keywords. We found out that 30% of the global VC funds invest in oncology, biotech, drug discovery and other related areas like immunology and pharmaceutical developments.

biotech keywords life science oncology

Focus on biotech, pharma, oncology, immunology and mRNA

The perviously introduced graph shows the most important keywords from our keyword search. We can see a strong focus on biotech, pharma and oncology keyword occurrences. Also immunology and mrna were often covered.

Reviews

There are no reviews yet.

Be the first to review “List of the 700 largest Biotech Venture Capital Investors [2022]”

Your email address will not be published. Required fields are marked *